🔎 Trials Near Me

Akèy › Limfòm Non-Hodgkin › Indiana

Etid klinik pou Limfòm Non-Hodgkin nan Indiana

10 etid pou Limfòm Non-Hodgkin ap chèche patisipan nan sit nan Indiana.

Vil nan Indiana

Tèks ofisyèl etid la (Anglè)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Community Health Network (The University of Texas MD Anderson Cancer Center), Indianapolis
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT02693535

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Indiana Blood and Marrow Transplantation, Indianapolis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Riley Hospital for Children, Indianapolis
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Indiana University/Riley Hospital for Children, Indianapolis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

  • Community Health Network, Indianapolis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT04068597

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Woodland Cancer Care Center, Michigan City
  • Reid Health, Richmond
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

  • Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • Sidney and Lois Eskenazi Hospital, Indianapolis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 10, 2026 · NCT06484920

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

  • American Oncology Partners, Fort Wayne
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 10, 2025 · NCT05602363

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

  • Goshen Center for Cancer Care, Goshen
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2022 · NCT04502394

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.